Engohan-Aloghe C, Hottat N, Cosaert J, Boutemy R, Fayt I, Noël J-C
Department of Pathology, Erasme University Hospital, Free University of Brussels (ULB), Brussels, Belgium.
Cytopathology. 2010 Jun;21(3):161-3. doi: 10.1111/j.1365-2303.2009.00652.x. Epub 2009 Sep 9.
To evaluate the accuracy of fine needle aspiration cytology (FNAC) in BI-RADS3 breast lesions.
Between January 2004 and December 2007, 337 cases from BI-RADS3 lesions underwent FNAC. Three to six needle passes were made on each patient. In 67 cases (20%) a histological biopsy was performed. Cytological and histological interpretations were performed by the same pathologist.
The histological diagnosis showed that 88% (59/67) of BI-RADS3 breast lesions were benign. Only 6% (4/67) were malignant, consisting of ductal carcinoma in situ and infiltrating ductal carcinoma.
BI-RADS3 lesions remain disruptive in their management. However, the correlation between cytology and histology showed that most of these lesions were benign and that finally FNAC remains a useful and accurate test in the management of these lesions.
评估细针穿刺细胞学检查（FNAC）在乳腺影像报告和数据系统（BI-RADS）3类乳腺病变中的准确性。
2004年1月至2007年12月期间，337例BI-RADS 3类病变患者接受了FNAC检查。每位患者进行3至6次穿刺。67例（20%）患者进行了组织活检。细胞学和组织学诊断由同一位病理学家进行。
组织学诊断显示，88%（59/67）的BI-RADS 3类乳腺病变为良性。仅6%（4/67）为恶性，包括导管原位癌和浸润性导管癌。
BI-RADS 3类病变在其管理方面仍然具有挑战性。然而，细胞学和组织学之间的相关性表明，这些病变大多数是良性的，最终FNAC在这些病变的管理中仍然是一种有用且准确的检查方法。
